Today is #WorldSclerodermaDay, a day created to tell people what it means to have scleroderma and recognize those who live with it. Join us today as we #SayScleroderma so that…
Read More
In 2014 at age 31, Katy was diagnosed with scleroderma. Though Katy has an identical twin sister (pictured here), they don’t share this diagnosis. This disease has been challenging for...
Read More
If you are in Austin, TX, you can support scleroderma research by going out to eat! Stop by any of the four Grove Wine Bar locations on Tuesday, June 28th...
Read More
Our third story of Scleroderma Awareness Month starts more than 31 years ago. Chip had “what I thought was an ingrown fingernail on my right index finger.” A game of...
Read More
SRF funded-investigator Dr. Howard Chang of the Stanford University School of Medicine is working on an innovative project to understand disease-relevant mechanisms in scleroderma: his novel Twin Study is investigating differences in genetically identical twins where one twin has scleroderma and...
Read More
“While eating supper one night, five-year-old Kate showed her purple hands to my wife, Becky,” says Kate’s father, Matt. “She did so in amazement, but we were quite concerned.” Four...
Read More
If you haven’t yet had the chance, we encourage you to check out Radio Rahim's moving podcast interview with SRF Board Member Bob Saget on Luminary’s Til This Day with Radio...
Read More
Double your impact with a gift to our 2022 Research Challenge! We’re excited to share that SRF Board Chair, Luke Evnin, PhD, and Research Committee Chair, Deann Wright, have once again committed…
Now available: the Scleroderma Research Foundation's latest Annual Report for FY 2021. You can read about the impact of donor support which allowed the SRF to invest $2.6 million in scleroderma research in the past...
Read More
You don't want to miss this month's edition of eNews. From an invite to our upcoming Cool Comedy • Hot Cuisine event to meaningful stories from our community for #SclerodermaAwarenessMonth,...
Read More
